A South Korean business daily reported that the LG Group has approached foreign investment banks and local law firms to discuss the listing of LG Electronics in India's stock market
The Ministry of Corporate Affairs' investigation offers some relief to Byju's, as it temporarily halts any new scrutiny by Indian officials on already investigated issues
Decarbonisation at Ijmuiden plant will be in two phases, with one blast furnace to be replaced before 2030
The National Company Law Tribunal (NCLT) Bengaluru on June 12 told Byju's to maintain the status quo with regard to existing shareholders and their shareholding
PhonePe is in advanced talks with major smartphone manufacturers to include its homegrown Indus Appstore in their devices
Hindustan Zinc Ltd on Friday said it has partnered with US-based AEsir Technologies, Inc for development of next-generation zinc batteries. The company has signed a memorandum of understanding (MoU) with AEsir Technologies, Inc., a company that specialises in next-generation zinc battery technologies, to be the preferred supplier of zinc, a key raw material, Hindustan Zinc Ltd (HZL) said in a statement. The MoU is in line with the company's efforts towards exploring emerging applications of zinc in the clean energy transition, it said, adding that zinc batteries are revolutionising energy storage due to their corrosion resistance, cost-effectiveness, recyclability, stability and environmental friendliness. "This partnership with AEsir Technologies is yet another step in our ongoing developmental work in the emerging clean technology space. "By providing high-quality zinc for cutting-edge energy storage, we are opening sophisticated new avenues for environmentally friendly solutions
Sun Pharmaceutical Industries on Friday said it has inked a licensing pact with Takeda Pharmaceutical Company to commercialise a novel gastrointestinal drug in India. The company has entered into a non-exclusive patent licensing agreement with Takeda to commercialise Vonoprazan tablets in strengths of 10 and 20 mg in India, the Mumbai-based drug major said in a statement. Vonoprazan is a novel, orally active potassium competitive acid blocker (PCAB), used to treat reflux esophagitis and other acid peptic disorders. "Sun Pharma is a leader in gastroenterology and we are excited to introduce Vonoprazan in India under non-exclusive patent license from Takeda," Sun Pharma CEO - India Business Kirti Ganorkar said. The partnership demonstrates the company's commitment to gastrointestinal health by providing patients and healthcare practitioners with a novel treatment option to manage reflux esophagitis and other acid peptic disorders, he added. Gastroesophageal Reflux Disease (GERD) is
The company claimed that at Rs 2 crore, MISSO is priced around 66 per cent lower than the available robotic knee replacement systems in the Indian market
OrbitShift claims that it has reduced research and sales planning time by 40-50%
This hike will be applicable across the entire range of commercial vehicles, with variations depending on individual models and variants
State-owned Energy Efficiency Services Ltd (EESL) on Wednesday said it has partnered with Andhra Pradesh Eastern Power Distribution Company Ltd (APEPDCL) to promote the adoption of energy efficiency and enable energy conservation within the power distribution sector. Under the 'Energy Efficient Appliance Programme', the partnership will provide a comprehensive energy efficiency solution to both residential and institutional consumers of APEPDCL. The discom portal will raise consumer awareness about the energy efficiency solutions programme through web portal, text messages, and WhatsApp. "EESL has signed an agreement with APEPDCL to promote the adoption of energy efficiency and enable energy conservation within the power distribution sector. The agreement aims to provide access to energy-efficient solutions, extending the benefits of savings of electricity bills for consumers at a large scale," EESL said in a statement. "This partnership is poised to deliver substantial benefits to
Deal value not revealed; regulator expected to release detailed order is likely later
Mobile phone manufacturers are exempt from this duty, whereas more complex PCB designs are also spared
Visa services provider BLS International on Tuesday said its subsidiary BLS E-Services Limited (BLSE) has signed an agreement to acquire 55 per cent in Aadifidelis Solutions and its affiliates for an enterprise value of about Rs 190 crore. BLSE has entered into a definitive Share Purchase Agreement (SPA) to acquire the controlling interest in Aadifidelis Solutions (ASPL) and its affiliates, a major player in India in the distribution and processing of loans for corporates and individuals. BLSE will make an upfront investment (primary and secondary) of about Rs 71 crore with balance consideration being deferred linked to the achievement of milestones in 2024-25, BLS said in a release. The acquisition will be an all-cash deal. The transaction will be completed in the second quarter of the fiscal. Shikhar Aggarwal, Joint Managing Director of BLS International Services said that the signing of a definitive agreement with ASPL is a strategic move that will unveil a plethora of ...
Jindal Stainless on Monday said it has acquired the remaining 46 per cent stake in Chromeni Steels Private Ltd (CSPL) for Rs 278 crore. Consequently, CSPL has become a wholly-owned subsidiary of the company, with effect from June 15, 2024, Jindal Stainless Ltd (JSL) said in a release. "Jindal Stainless acquires remaining 46 per cent equity stake in Chromeni Steels Private Ltd. The transaction entails a total outlay of Rs 278 crore, comprising payment towards equity transfer and payment of shareholders' debt," it said. Jindal Stainless earlier acquired a 54 per cent equity stake in CSPL through an indirect acquisition deal for Rs 1,340 crore. The overall acquisition of CPSL costs around Rs 1,618 crore to JSL. JSL CEO Tarun Kumar Khulbe said, "The acquisition of a 100 per cent equity stake in Chromeni will help us climb the value chain. Since we expect the facility to be operational soon, this strategic move will enable the company to capitalise on the robust domestic demand, which
Solid surface manufacturer Durlax Top Surface plans to raise around Rs 40.80 crore through its initial public offer which will open for subscription on June 19, a statement said on Monday. The company, which has been involved in the business of solid surface for over a decade, has received approval to launch its public issue on the NSE Emerge Platform of the National Stock Exchange, Durlax Top Surface said in the statement. The company has fixed the price band at Rs 65-68 per share for the issue of 60 lakh shares which will open for subscription from June 19 to June 21, it added. The IPO comprises a fresh issue of 42 lakh shares worth up to Rs 28.56 crore and an Offer for Sale of 18 lakh shares worth up to Rs 12.24 crore. Out of the fresh issue of Rs 28.56 crore, the company plans to utilise Rs 17.50 crore to part finance working capital requirements and Rs 6 crore towards general corporate purposes. Investors can bid for a minimum of 2,000 shares and in multiples thereof. Promot
Suven Pharmaceuticals on Thursday said it will acquire 67.5 per cent stake in Hyderabad-based Sapala Organics for Rs 229.5 crore. The company, which is one of the country's largest integrated contract development and manufacturing organisation players, has entered into a definitive agreement for investment in Sapala Organics, it said in a regulatory filing. Suven will acquire a 67.5 per cent stake for a consideration of Rs 229.5 crore, subject to customary working capital and net debt adjustments, it added. The company stated that it expects to complete the acquisition of the remaining equity stake in the target firm after FY2026-27, subject to the completion of customary closing conditions. Sapala has a presence in the fast-growing, Oligo and nucleic acid building blocks segment. "We see massive potential given it's a niche technology in the rapidly growing space. Nucleic acid based therapy targets diseases at a genetic level and has the potential to help patients immensely and c
Intel did not give any specific reason for the decision and made no link to the ongoing war in Gaza, in which over 37,000 Palestinians have been killed
Bengaluru-based real estate company aims to double growth in Chennai
The initial public offer of Le Travenues Technology, which operates travel booking platform ixigo, got subscribed 98.10 times on the closing day of subscription on Wednesday. The Rs 740-crore initial share sale received bids for 4,29,36,34,618 shares against 4,37,69,494 shares on offer, as per NSE data. The quota for non-institutional investors fetched 110.25 times subscription while the portion for Qualified Institutional Buyers (QIBs) got subscribed 106.73 times. The category for Retail Individual Investors (RIIs) received 53.95 times subscription. The initial public offering (IPO) of Le Travenues Technology got subscribed 1.95 times on the first day of subscription on Monday. The IPO has a fresh issue of up to Rs 120 crore and an offer for sale (OFS) of up to 6,66,77,674 equity shares. Proceeds worth Rs 45 crore from the fresh issue will be used to fund the company's working capital requirements and Rs 26 crore will be utilised for investments in technology as well as data scie